InvestorsHub Logo
Followers 260
Posts 15904
Boards Moderated 0
Alias Born 08/05/2009

Re: Solantey post# 23020

Sunday, 01/20/2013 2:28:31 PM

Sunday, January 20, 2013 2:28:31 PM

Post# of 130517
Solantey your AMBS $1.00 PPS prediction is low considering...


CEO BLOG (1/14/2013) Onwards and Upwards: Building Value From a Solid Foundation

SOURCE: http://www.thechairmansblog.com/gerald-commissiong/2013-01/onwards-and-upwards-building-value-from-a-solid-foundation.html



"Big pharma" development partnership(s) or buyout in 2013. $1.00 or more.AMBS is the most undervalued bio-tech in the market." Solantey





Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None



"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.



http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

Never buy a stock based on my opinion of that stock.Form your own opinion by doing your own DD.My position on any stock I buy can change without notice.I am not a licensed broker or stock adviser and I really don't know what I'm doing.